Mutations in the gene for the transcription factor hepatocyte nuclear factor (HNF) 1alpha cause maturity-onset diabetes of the young (MODY) 3, a form of diabetes that results from defects in insulin secretion. Since the nature of these defects has not been defined, we compared insulin secretory function in heterozygous [HNF-1alpha (+/-)] or homozygous [HNF-1alpha (-/-)] mice with null mutations in the HNF-1alpha gene with their wild-type littermates [HNF-1alpha (+/+)]. Blood glucose concentrations were similar in HNF-1alpha (+/+) and (+/-) mice (7.8+/-0.2 and 7.9+/-0.3 mM), but were significantly higher in the HNF-1alpha (-/-) mice (13.1+/-0.7 mM, P < 0.001). Insulin secretory responses to glucose and arginine in the perfused pancreas and perifused islets from HNF-1alpha (-/-) mice were < 15% of the values in the other two groups and were associated with similar reductions in intracellular Ca2+ responses. These defects were not due to a decrease in glucokinase or insulin gene transcription. beta cell mass adjusted for body weight was not reduced in the (-/-) animals, although pancreatic insulin content adjusted for pancreas weight was slightly lower (0.06+/-0.01 vs. 0.10+/-0.01 microg/mg, P < 0.01) than in the (+/+) animals. In summary, a null mutation in the HNF-1alpha gene in homozygous mice leads to diabetes due to alterations in the pathways that regulate beta cell responses to secretagogues including glucose and arginine. These results provide further evidence in support of a key role for HNF-1alpha in the maintenance of normal beta cell function.
M Pontoglio, S Sreenan, M Roe, W Pugh, D Ostrega, A Doyen, A J Pick, A Baldwin, G Velho, P Froguel, M Levisetti, S Bonner-Weir, G I Bell, M Yaniv, K S Polonsky
Title and authors | Publication | Year |
---|---|---|
Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3 M Hu, X Huang, X Han, L Ji |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2020 |
Modeling different types of diabetes using human pluripotent stem cells
EM Abdelalim |
Cellular and Molecular Life Sciences | 2020 |
The Roles of Long Noncoding RNAs HNF1α-AS1 and HNF4α-AS1 in Drug Metabolism and Human Diseases
L Chen, Y Bao, S Jiang, X Zhong |
Non-Coding RNA | 2020 |
HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1
Y Sato, M Rahman, M Haneda, T Tsuyama, T Mizumoto, T Yoshizawa, T Kitamura, F Gonzalez, K Yamamura, K Yamagata |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2020 |
HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1
Y Sato, M Rahman, M Haneda, T Tsuyama, T Mizumoto, T Yoshizawa, T Kitamura, FJ Gonzalez, K Yamamura, K Yamagata |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2020 |
Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment
KM Jang |
Yeungnam University Journal of Medicine | 2020 |
Transcriptional Regulation of the Angptl8 Gene by Hepatocyte Nuclear Factor-1 in the Murine Liver
T Watanabe, A Ozawa, S Masuda, S Yoshino, E Ishida, Y Kondo, S Matsumoto, A Katano-Toki, K Horiguchi, Y Nakajima, E Yamada, T Tomaru, T Saito, S Ishii, N Shibusawa, S Okada, T Satoh, M Yamada |
Scientific Reports | 2020 |
Update on Monogenic Diabetes in Korea
YS Yang, SH Kwak, KS Park |
Diabetes & Metabolism Journal | 2020 |